Canada markets closed

Biomerica, Inc. (BMRA)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
2.9000-0.0800 (-2.68%)
At close: 04:00PM EST
2.9000 0.00 (0.00%)
After hours: 04:14PM EST
Full screen
Trade prices are not sourced from all markets
Previous Close2.9800
Bid2.9000 x 800
Ask2.9500 x 1000
Day's Range2.8500 - 3.0003
52 Week Range2.5600 - 5.2500
Avg. Volume27,008
Market Cap39.09M
Beta (5Y Monthly)-0.54
PE Ratio (TTM)N/A
EPS (TTM)-0.2800
Earnings DateApr 12, 2023 - Apr 17, 2023
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est13.00
  • GlobeNewswire

    Barnwell Industries, Inc. Reaches Cooperation and Support Agreement With its Largest Stockholders

    Agrees to Reconstitute Its Board and Extend Standstill AgreementHONOLULU, Jan. 23, 2023 (GLOBE NEWSWIRE) -- Barnwell Industries, Inc. (NYSE-American: BRN) (“Barnwell” or the “Company”) announce today that it has entered into a cooperation and support agreement (the “Agreement”) with its two largest stockholders, Alexander C. Kinzler, who beneficially owns approximately 9.3% of the Company’s outstanding common stock, and MRMP-Managers LLC, Ned L. Sherwood Revocable Trust, and Ned L. Sherwood (col

  • GlobeNewswire

    Biomerica Reports Financial Results for Fiscal 2023 Second Quarter Ended November 30, 2022

    InFoods® IBS Data Receives American College of Gastroenterology Presidential Award (ACG) Following Presentation at Annual Scientific Meeting Trial Data Shows InFoods® IBS Treatment Diet Significantly Improved Several IBS Symptoms Including Abdominal Pain Intensity (API): In Some Cases Better Than Certain Currently Marketed Drugs Launch of InFoods® IBS Lab Developed Test Expected in Fiscal 3Q Amazon Now Fulfills Sales of Aware® Breast Self Exam and EZ Detect™ Colon Disease Tests IRVINE, Calif., J

  • GlobeNewswire

    Biomerica Appoints Mayo Clinic Gastroenterologist, Dr. Brian E. Lacy, to the Company’s Scientific Advisory Board

    Dr. Lacy is the former co-Editor in Chief of the American Journal of Gastroenterology, the former Editor in Chief of Clinical and Translational Gastroenterology, and has served as the co-Chairman for the Rome IV Committee on Functional Bowel Disorders. Dr. Lacy has authored over 225 peer reviewed articles IRVINE, Calif., Jan. 10, 2023 (GLOBE NEWSWIRE) -- Biomerica, Inc. (Nasdaq: BMRA) (the “Company”) appointed prominent physician and key opinion leader Brian E. Lacy, M.D., Ph.D., a board-certifi